Gene therapy for cardiovascular diseases in China: basic research.

Area of Science:

• Biomedical research
• Molecular biology
• Cardiology

Background:

• Cardiovascular diseases (CVDs) are a leading global health concern.
• Gene therapy involves introducing normal genes to correct defects, showing potential for CVD treatment.
• China has made significant strides in CVD pathogenesis and gene therapy research.

Purpose of the Study:

• To review recent advancements in gene therapy for cardiovascular diseases in China.
• To highlight research on gene therapy targeting myocardial infarction, cardiac ischemia-reperfusion injury, atherosclerosis, and muscle atrophy.
• To identify potential therapeutic targets for cardiovascular diseases through basic gene therapy research.

Main Methods:

• Review of the latest research on gene therapy approaches in China.
• Focus on protein-based gene therapy, epigenetics (including noncoding RNAs), and genome-editing technology.
• Analysis of studies related to myocardial infarction, cardiac ischemia-reperfusion injury, atherosclerosis, and muscle atrophy.

Main Results:

• Significant progress in basic gene therapy research for cardiovascular diseases in China.
• Identification of key roles for gene therapy in understanding and treating various cardiovascular conditions.
• Emerging findings in noncoding RNA and genome-editing applications for cardiovascular repair.

Conclusions:

• Gene therapy holds substantial promise for treating cardiovascular diseases.
• Recent Chinese research provides valuable insights into therapeutic targets for CVDs.
• Continued basic research is crucial for advancing gene therapy applications in cardiology.